This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of January 2019. Because of its value to the laboratory community, it is being retained in CLSI's library.
This guideline details procedures for the manufacture and evaluation of human serum pools for cholesterol measurement.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
This guideline details procedures for the manufacture and evaluation of human serum pools for cholesterol measurement.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guideline for use in satisfying a regulatory requirement.
More CLSI standard pdf
CLSI M43-A
Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline, M43AE
$90.00 $180.00
CLSI EP23-A (R2018)
Laboratory Quality Control Based on Risk Management; Approved Guideline, EP23AE
$90.00 $180.00
CLSI VET05-R (R2018)
Generation, Presentation, and Application of Antimicrobial Susceptibility Test Data for Bacteria of Animal Origin; A Report, VET05RE
$90.00 $180.00
CLSI QMS13-A (R2018)
Quality Management System: Equipment; Approved Guideline, QMS13AE
$90.00 $180.00